Physician profile
Ying Liu
NPI 1720385503
$1,135.67
in general payments reported to CMS, 2019-2025
15 companies · $597 in 2025
The $597 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2022: $237 · 2023: $21.69 · 2024: $162 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $302.90 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $146.65 | 2025 | |
| Lilly USA, LLC | $134.85 | 2024-2025 | Mounjaro, Zepbound |
| Coopersurgical, INC. | $117.81 | 2019 | |
| Amgen INC. | $87.90 | 2024-2025 | Repatha, Otezla, Repatha |
| Azurity Pharmaceuticals, INC. | $77.09 | 2024-2025 | Horizant |
| Dexcom, INC. | $54.89 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $44.27 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $38.00 | 2025 | Shingrix |
| Abbott Laboratories | $33.54 | 2025 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $28.94 | 2025 | Aptima |
| E.R. Squibb & Sons, L.L.C. | $19.10 | 2025 | Eliquis |
| Ferring Pharmaceuticals INC. | $18.98 | 2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $16.34 | 2025 | Farxiga |
| Merck Sharp & Dohme LLC | $14.41 | 2024 | Gardasil, Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.